Yubaiolifics Signs $101.217 Billion Cholera Vaccine Supply Agreement with UNICEF

Yubaiolifics, a cholera vaccine developer, announced on July 14 that it has signed a contract to supply oral cholera vaccine Ubico-ES to UNICEF. The contract amount is 101.217 billion won (673.7023 million USD as of July 13, 2026, based on Hana Bank's exchange rate of 1,499.50 won per USD), representing 6.77% of its recent revenue of 1,491.9502 billion won. The contract, with UNICEF as the counterparty, involves supplying vaccines to the Democratic Republic of Congo from July 13 to September 12, 2026. Payment terms include 30-day settlement after document submission with no advance payments. The company, listed on KOSDAQ since January 24, 2017, reported assets of 240.2 billion won, liabilities of 64.9 billion won, revenue of 1,492 billion won, and net profit of 413 billion won as of its December 2025 financial statements. Its stock closed at 7,930 won on July 14, down 0.38% from the prior day.